학술논문

Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Document Type
Article
Source
Oncologist; May2022, Vol. 27 Issue 5, p338-338, 1p, 1 Diagram, 2 Graphs
Subject
DRUG efficacy
CARDIOTOXICITY
MITOXANTRONE
INTRAVENOUS therapy
CONFIDENCE intervals
METASTASIS
ANTINEOPLASTIC agents
TREATMENT effectiveness
RANDOMIZED controlled trials
SURVIVAL analysis (Biometry)
QUALITY of life
DESCRIPTIVE statistics
STATISTICAL sampling
PROGRESSION-free survival
BREAST tumors
PATIENT safety
EVALUATION
Language
ISSN
10837159
Abstract
Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)